What are the differences in metabolic outcomes when using GLP-1 analogues compared to other treatments for obesity in adolescents?

GLP-1 receptor agonists show superior efficacy in weight reduction and some metabolic improvements in adolescents with obesity compared to other treatments, although the long-term metabolic benefits and safety profile necessitate further study.